CDEK
← All organizations
Inhibrx, Inc.

Inhibrx, Inc.

For profitWebsite ↗

Also known as: Inhibrx Biosciences, Inc | Inhibrx, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 5, 2018

Last known activity

Sep 5, 2024

Acquired by Sanofi-Aventis on Jan 23, 2024

Timeline

2010s

  1. Apr 1, 2010

    Inhibrx, Inc.— Founded

2020s

  1. Jan 23, 2024

    Sanofi-Aventis— Acquired By

Drugs by trial phase (6 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

Details

Founded
La Jolla, CA, US Apr 1, 2010
Last known activity
Sep 5, 2024